| Literature DB >> 30787169 |
Donald Y M Leung1, Agustin Calatroni2, Livia S Zaramela3, Petra K LeBeau2, Nathan Dyjack4, Kanwaljit Brar4, Gloria David2, Keli Johnson2, Susan Leung4, Marco Ramirez-Gama4, Bo Liang3, Cydney Rios4, Michael T Montgomery4, Brittany N Richers4, Clifton F Hall4, Kathryn A Norquest4, John Jung4, Irina Bronova4, Simion Kreimer5, C Conover Talbot5, Debra Crumrine6, Robert N Cole5, Peter Elias6, Karsten Zengler3, Max A Seibold4, Evgeny Berdyshev4, Elena Goleva4.
Abstract
Skin barrier dysfunction has been reported in both atopic dermatitis (AD) and food allergy (FA). However, only one-third of patients with AD have FA. The purpose of this study was to use a minimally invasive skin tape strip sampling method and a multiomics approach to determine whether children with AD and FA (AD FA+) have stratum corneum (SC) abnormalities that distinguish them from AD without FA (AD FA-) and nonatopic (NA) controls. Transepidermal water loss was found to be increased in AD FA+. Filaggrin and the proportion of ω-hydroxy fatty acid sphingosine ceramide content in nonlesional skin of children with AD FA+ were substantially lower than in AD FA- and NA skin. These abnormalities correlated with morphologic changes in epidermal lamellar bilayer architecture responsible for barrier homeostasis. Shotgun metagenomic studies revealed that the nonlesional skin of AD FA+ had increased abundance of Staphylococcus aureus compared to NA. Increased expression of keratins 5, 14, and 16 indicative of hyperproliferative keratinocytes was observed in the SC of AD FA+. The skin transcriptome of AD FA+ had increased gene expression for dendritic cells and type 2 immune pathways. A network analysis revealed keratins 5, 14, and 16 were positively correlated with AD FA+, whereas filaggrin breakdown products were negatively correlated with AD FA+. These data suggest that the most superficial compartment of nonlesional skin in AD FA+ has unique properties associated with an immature skin barrier and type 2 immune activation.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30787169 PMCID: PMC7676854 DOI: 10.1126/scitranslmed.aav2685
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956